Quick Answer
IMMUCELL CORP /DE/ reported Cash And Cash Equivalents At Carrying Value of $3.81 million for the year ending 2025.
- IMMUCELL CORP /DE/ showed an increase of +1.3% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from IMMUCELL CORP /DE/'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: $1.74 million | Q3 2010: $2.83 million | Q1 2011: $887.4 thousand | Q2 2011: $891.2 thousand | Q3 2011: $563.5 thousand | Q1 2012: $1.57 million | Q2 2012: $1.03 million | Q3 2012: $1.59 million | Q1 2013: $2.32 million | Q2 2013: $2.44 million | Q3 2013: $2.94 million | Q1 2014: $2.24 million | Q2 2014: $1.70 million | Q3 2014: $1.17 million | Q1 2015: $2.47 million | Q2 2015: $1.93 million | Q3 2015: $2.47 million | Q1 2016: $4.56 million | Q2 2016: $3.65 million | Q3 2016: $4.41 million | Q1 2017: $4.25 million | Q2 2017: $3.85 million | Q3 2017: $2.31 million | Q1 2018: $3.06 million | Q2 2018: $2.51 million | Q3 2018: $2.39 million | Q1 2019: $10.58 million | Q2 2019: $1.30 million | Q3 2019: $2.35 million | Q1 2020: $6.51 million | Q2 2020: $6.20 million | Q3 2020: $3.92 million | Q1 2021: $6.81 million | Q2 2021: $10.70 million | Q3 2021: $10.50 million | Q1 2022: $11.82 million | Q2 2022: $11.04 million | Q3 2022: $8.83 million | Q1 2023: $3.10 million | Q3 2023: $1.99 million | Q4 2023: $978.7 thousand | Q1 2024: $960.3 thousand | Q2 2024: $1.32 million | Q3 2025: $3.89 million.
- Over the full 18 years of available data (2008 to 2025), IMMUCELL CORP /DE/'s Cash And Cash Equivalents At Carrying Value has grown by 217.3%.
- Historical annual values: Fiscal year 2025: $3.81 million | Fiscal year 2024: $3.76 million | Fiscal year 2023: $978.7 thousand | Fiscal year 2022: $5.79 million | Fiscal year 2021: $10.19 million | Fiscal year 2020: $6.95 million | Fiscal year 2019: $6.29 million | Fiscal year 2018: $2.52 million | Fiscal year 2017: $3.80 million | Fiscal year 2016: $5.15 million | Fiscal year 2015: $1.57 million | Fiscal year 2014: $850.0 thousand | Fiscal year 2013: $2.27 million | Fiscal year 2012: $2.67 million | Fiscal year 2011: $781.5 thousand | Fiscal year 2010: $1.40 million | Fiscal year 2009: $975.5 thousand | Fiscal year 2008: $1.20 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: